B. Riley analyst Mayank Mamtani reiterates a Buy rating on Viking Therapeutics (VKTX) with a $96 price target after the ...
Operator: Good morning and welcome to Agenus Inc.’s Fourth Quarter and Year-End 2024 Earnings Conference Call. Currently all ...
Good morning, and welcome to Agenus Inc.'s fourth-quarter and year-end 2024 earnings conference call. (Operator Instructions) As a reminder, this conference is being recorded. I will now turn the call ...
Good morning, and welcome to Agenus Inc.'s fourth-quarter and year-end 2024 earnings conference call. Currently, all ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results